[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100404318":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":10,"centralContacts":26,"locations":36,"responsibleParty":74,"collaborators":76,"id":79,"slug":80,"hasResults":81,"nctId":82,"briefTitle":83,"officialTitle":84,"acronym":10,"eligibilityCriteria":85,"healthyVolunteers":81,"sex":86,"minAge":87,"maxAge":88,"enrollmentInfo":89,"targetDuration":92,"studyType":93,"phases":10,"briefSummary":94,"conditions":95,"keywords":10,"overallStatus":39,"whyStopped":10,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":103,"completionDateStruct":105,"leadSponsor":107,"locationsCount":108},{"fullName":5,"class":6},"Universitaire Ziekenhuizen KU Leuven","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Allergic rhinitis patients",null,"Patients with persistent or intermittent allergic rhinitis complaints, confirmed by skin prick tests and\u002For immunocap for specific IgEs, that start with AIT treatment.",[13,14],"Drug: AIT","Diagnostic Test: NAPT",[16,21],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":10},"DRUG","AIT","AIT for airborn allergens (SCIT\u002FSLIT)",[9],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":10},"DIAGNOSTIC_TEST","NAPT","NAPT test with airborn allergens ( HDM, Threes, Grasses)",[9],[27,32],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},"Margot Vandekerckhove","CONTACT","+3216332342","margot.vandekerckhove@uzleuven.be",{"name":33,"role":29,"phone":34,"phoneExt":10,"email":35},"Laura Van Gerven, PhD","+3216336340","laura.vangerven@uzleuven.be",[37,59],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"UZ Leuven","RECRUITING","Leuven","Vlaam Brabant","3000","Belgium","BE",{"type":46,"coordinates":47},"Point",[48,49],4.70093,50.87959,{"lat":49,"lon":48},[52,53,56],{"name":28,"role":29,"phone":30,"phoneExt":30,"email":31},{"name":54,"role":29,"phone":55,"phoneExt":34,"email":35},"Laura Van Gerven","+3216336390",{"name":57,"role":58,"phone":10,"phoneExt":10,"email":10},"Laura Van Gerven, MD, PhD","PRINCIPAL_INVESTIGATOR",{"facility":60,"status":61,"city":62,"state":10,"zip":63,"country":43,"countryCode":44,"cosmosGeoPoint":64,"geoPoint":68,"contacts":69},"AZ Sint-Jan","NOT_YET_RECRUITING","Bruges","8000",{"type":46,"coordinates":65},[66,67],3.22424,51.20892,{"lat":67,"lon":66},[70],{"name":71,"role":29,"phone":72,"phoneExt":10,"email":73},"Kato Speleman, MD","050452280","nok@azsintjan.be",{"type":58,"investigatorFullName":54,"investigatorTitle":75,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"prof. dr. Laura Van Gerven",[77],{"name":78,"class":6},"AZ Sint-Jan AV","100404318","the-role-of-the-nasal-allergen-provocation-test-in-starting-and-monitoring-allergen-immunotherapy-100404318",false,"NCT04544774","The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy","The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy: An Academic Multicentre Clinical Study","Inclusion Criteria:\n\n* Age \\>18 and ≤60 years\n* Persistent or intermittent allergic rhinitis complaints, confirmed by SPT and\u002Fof immunocap for the specific IgEs.\n\nOR suspected local allergic rhinitis\n\n* Patients who start with AIT treatment\n* The patient must be motivated and willing to come to all visits\n* The patient must be able to understand and sign the informed consent\n\nExclusion Criteria:\n\n* Uncontrolled asthma\n* Conditions affecting the functioning of the immune system (eg: immune deficiencies, malignancies, autoimmune diseases)\n* Use of β-blockers, immunosuppressants or ACE inhibitors\n* Hypersensitivity to aluminum hydroxide and\u002For hypersensitivity to any of the excipients in AIT\n* Anaphylaxis after allergen challenge in the past\n* Acute rhinosinusitis in the last 12 weeks\n* Recent surgery on the nose and\u002For paranasal sinuses in the last 12 weeks\n* Pregnancy","ALL","18 Years","60 Years",{"count":90,"type":91},200,"ESTIMATED","3 Years","OBSERVATIONAL","This prospective multicentric academic NAPT study aims to compile a database of all patients who initiate immunotherapy.\n\nThe NAPT will take place before, during and after AIT to evaluate the cost and effectiveness of the treatment. The study consists of 4 visits and 2 telephone contacts that are repeated annually for 3 years.\n\nThis study will be conducted in 2 hospitals: UZ Leuven and AZ ST. Jan Brugge on the consultation Ear, Nose and Throat Diseases (ENT) and the department of Internal Medicine \u002F Allergology",[96,97,98],"Perennial Allergic Rhinitis","Seasonal Allergic Rhinitis","Local Allergic Rhinitis","2026-04-30",{"date":101,"type":102},"2026-05-01","ACTUAL",{"date":104,"type":102},"2020-07-16",{"date":106,"type":91},"2026-12",{"name":5,"class":6},2]